Phase I safety and immunogenicity study of NY-ESO-1b peptide and Montanide ISA-51 vaccination of patients with ovarian cancer (OC) in high risk first remission Meeting Abstract


Authors: Diefenbach, C. S. M.; Sabbatini, P.; Aghajanian, C.; Spriggs, D.; Lee, H.; Pezzulli, S.; Jungbluth, A. A.; Old, L. J.; Gnjatic, S.; Dupont, J.
Abstract Title: Phase I safety and immunogenicity study of NY-ESO-1b peptide and Montanide ISA-51 vaccination of patients with ovarian cancer (OC) in high risk first remission
Meeting Title: 42nd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 24
Issue: 18 Suppl. Pt. 1
Meeting Dates: 2006 Jun 2-6
Meeting Location: Atlanta, GA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2006-06-01
Start Page: 275S
Language: English
ACCESSION: WOS:000239009401532
PROVIDER: wos
Notes: --- - Meeting Abstract: 5078 - 42nd Annual Meeting of the American-Society-of-Clinical-Oncology - JUN 02-06, 2006 - Atlanta, GA - S - Part 1 - "Source: Wos"
MSK Authors
  1. Jakob Dupont
    64 Dupont
  2. Paul J Sabbatini
    199 Sabbatini
  3. David R Spriggs
    307 Spriggs
  4. Sacha Gnjatic
    111 Gnjatic
  5. Achim Jungbluth
    337 Jungbluth
  6. Lloyd J Old
    381 Old
  7. Helen Lee
    2 Lee